News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 838
- Sources here
- 19
- Companies here
- 21
Active search
838 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Citizens Financial Group (CFG) files Form 13F with $8.3B across 1,257 positions
Citizens Financial Group (CFG) has filed a Form 13F combination report, disclosing institutional investment holdings totaling over $8.3 billion across 1,257 positions. The report indicates that two affiliated managers, Citizens Bank, National Association and Citizens Private Wealth, LLC, are also included. This filing provides …
Citizens & Northern Corporation Announces Q2 2026 Financial Results with Strong Net Income Growth
Citizens & Northern Corporation has announced its Q2 2026 financial results, reporting strong net income growth. The Pennsylvania-based bank holding company filed its Form 10-Q with the SEC for the quarter ended June 30, 2026. The article indicates that full details require logging in …
Friday Sector Laggards: Grocery & Drug Stores, Life & Health Insurance Stocks
In trading on Friday, grocery & drug stores shares were relative laggards, down on the day by about 1.5%. Helping drag down the group were shares of ARKO, off about 14.1% and shares of Natural Grocers By Vitamin Cottage off about 12.3% on the …
AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AstraZeneca (LSE:AZN) is back in focus after a senior source told Reuters that there are no ongoing merger discussions with Bristol Myers Squibb, reversing earlier …
Citizens & Northern: Q2 Earnings Snapshot
Citizens & Northern Corp. (CZNC) reported a net income of $14.1 million for its second quarter, with earnings of 79 cents per share. The Wellsboro, Pennsylvania-based bank recorded revenue of $51.4 million, and its revenue net of interest expense was $39.7 million, surpassing Street …
Citizens & Northern Corp (CZNC) Earnings Forecast: Future EPS & Revenue Growth Estimates
Citizens & Northern Corp (CZNC) has an earnings forecast score of 6.00, ranking it 286 out of 395 in the Banking Services industry. Analysts have set an average price target of $21.50, with one analyst recommending a "Hold" rating for the stock. The company's …
Total liabilities of Citizens Financial Group, Inc. – HAM:1C5
This article provides financial information for Citizens Financial Group, Inc. (HAM:1C5) on TradingView, focusing specifically on its total liabilities. It mentions the company's presence on the Hamburg Stock Exchange and indicates that market data is provided by ICE Data Services and FactSet. The core …
1C5 Stock Price and Chart — HAM:1C5
This page provides a detailed overview of Citizens Financial Group, Inc. (1C5) stock on the Hamburg Stock Exchange, including its key financial statistics, upcoming earnings reports, and analyst ratings. It also features various trading ideas and analyses from different users, offering diverse perspectives on …
Loan losses (actual) of Citizens Financial Group, Inc. – HAM:1C5
This page provides financial data on the actual loan losses of Citizens Financial Group, Inc. (HAM:1C5), listed on the Hamburg Stock Exchange. The content is primarily a data page, indicating that the market was closed with no trades at the time of viewing.
Citizens Financial Services Inc (CZFS) Earnings Forecast: Future EPS & Revenue Growth Estimates
Citizens Financial Services Inc (CZFS) has an earnings forecast score of 8.00, ranking 53rd in the Banking Services industry. Analysts project a price target of $64.36 with a "Buy" rating. The company's expected revenue for the next quarter is $25.80 million, with an anticipated …
Zentalis Pharmaceuticals, Inc. 2Q 2026: Net loss $(42.3M), EPS $(0.59) — 10-Q Summary
Zentalis Pharmaceuticals, Inc. reported a net loss of $(42.3M) and a diluted loss per share of $(0.59) for the second quarter of 2026, remaining a pre-revenue company. The company is advancing its clinical development for azenosertib, including a Phase 3 study and biomarker strategy, …
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This follows Azenta's Q2 2026 financial results, which missed consensus estimates for EPS and revenue, reported a $149 million goodwill impairment, and led to a reduced …
Surrozen, Inc. 2Q 2026: Revenue $5M, Net income $50.18M, EPS $(0.41) — 10-Q Summary
Surrozen, Inc. reported its second-quarter 2026 results, showing a significant increase in revenue to $5M, up 408% year-over-year, and net income of $50.18M. This growth was primarily driven by collaboration milestone recognition and noncash fair value gains. The company also highlighted pipeline progress with …
Citizens Financial pauses just below its high while a 54-week trend streak stays intact
CFG finished the week at $71.65, only 3.5% beneath its 52-week high, with regional-bank breadth supportive but volume still no better than baseline.
Citizens & Northern Corp (CZNC) director adds to holdings under 10b5-1 plan
Citizens & Northern Corp director Katherine W. Shattuck purchased 8 shares of common stock at $25.215 per share on August 7, 2026, through an open-market transaction under a pre-existing Rule 10b5-1 trading plan. Following this acquisition, her direct holdings in CZNC increased to 10,601 …
Morgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating
Morgan Stanley has increased its price target for Zentalis Pharmaceuticals (ZNTL) from $4 to $5, while reiterating an "Equalweight" rating on the stock. This adjustment reflects a modest upgrade in the firm's outlook for the clinical-stage biopharmaceutical company, which specializes in developing small molecule …
How the FTSE became a ‘departure lounge’ for British companies
On holiday in Devon this summer, Charles Hall felt a familiar sinking feeling. The most senior analyst at City stockbroker Peel Hunt had just read that AstraZeneca held talks with US pharmaceutical giant Bristol Myers Squibb about a potential merger. It reignited concerns that …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
Pomerantz LLP is investigating potential claims on behalf of investors of AstraZeneca PLC (NYSE: AZN) following a significant drop in its stock price. This investigation comes after AstraZeneca disclosed that its late-stage Phase-3 CARDIO-TTransform trial for Wainua, an amyloid cardiomyopathy treatment, failed to meet …
Citizens Financial Services (CZFS) 10K Form and Latest SEC Filings 2026
This article provides an overview of Citizens Financial Services (CZFS) SEC filings, highlighting that the company has submitted over 762 documents since 2017. It details recent filings including a Form 10-Q on August 6, 2026, a Form 8-K on July 30, 2026, and various …
ZenaTech closes 27th Drone as a Service acquisition, expands into Idaho
ZenaTech has completed its 27th Drone as a Service acquisition, extending its operations into Idaho. This strategic move aims to strengthen its drone-based surveying and civil engineering services for both government and construction clients. The information was originally published by Zenatech Inc. via EDGAR …
Zentek Ltd (ZTEK) Stock News Today
This article provides the latest stock news for Zentek Ltd (ZTEK) on TradingKey. It shows the current stock price, market capitalization, and a general overview of the company's financial information and news. The content indicates that more news will be coming soon for Zentek …
Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA
Arrowstreet Capital Limited Partnership has acquired a new position in Azenta, Inc. (NASDAQ:AZTA), purchasing 71,410 shares valued at approximately $1.51 million, representing about 0.15% of the company. This comes as Azenta reported strong quarterly earnings, exceeding analyst estimates for both EPS and revenue, though …
ZenaTech, Inc. acquired Benchmark Partners LLC.
ZenaTech, Inc. (NasdaqCM:ZENA) announced the acquisition of Benchmark Partners LLC, which was completed on August 6, 2026. This acquisition is part of ZenaTech's ongoing expansion, following several other recent acquisitions and inclusions in various Russell indexes. ZenaTech specializes in AI drones, Drone as a …
Zenas BioPharma, Inc. (ZBIO) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 16, 2025
Levi & Korsinsky is urging investors who suffered losses in Zenas BioPharma, Inc. (ZBIO) to contact them before June 16, 2025, regarding a potential lawsuit. The lawsuit alleges that Zenas BioPharma made false statements about its ability to fund operations following its September 2024 …